ConductScience.org, home

Paper1333367

Relationships between various uses of antineoplastic drug-interaction terms.

Wampler GL and 3 others. Cancer Chemother Pharmacol, 1992. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Relationships between various uses of antineoplastic drug-interaction terms. Papers, record 1333367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1333367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationships between various uses of antineoplastic drug-interaction terms.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wampler GLG L
2Carter WH JrW H
3Campbell EDE D
4Keefe PAP A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Drug SynergismMajor topic
Terminology as TopicMajor topic
Animals
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Small Cell
Cisplatin
Etoposide
Humans
Leukemia P388
Lung Neoplasms
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1679196Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.Cancer Res1978https://conductscience.org/library/papers/679196PubMed
26387058Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.J Clin Oncol1984https://conductscience.org/library/papers/6387058PubMed
3476674An improved method for analyzing survival data from combination chemotherapy experiments.Cancer Res1979https://conductscience.org/library/papers/476674PubMed
43442730Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.Cancer Invest1987https://conductscience.org/library/papers/3442730PubMed
56807534Drug activity and therapeutic synergism in cancer treatment.Cancer Res1982https://conductscience.org/library/papers/6807534PubMed
64771975Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.Acta Pathol Microbiol Scand A1973https://conductscience.org/library/papers/4771975PubMed
72706626Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).Cancer Res1989https://conductscience.org/library/papers/2706626PubMed
82593167Synergistic antitumor activity of etoposide and human interleukin-1 alpha against human melanoma cells.J Natl Cancer Inst1989https://conductscience.org/library/papers/2593167PubMed
93581096Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.Cancer Treat Rep1987https://conductscience.org/library/papers/3581096PubMed
102386940Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.Cancer Res1990https://conductscience.org/library/papers/2386940PubMed
113038314In vitro chemosensitivity of human lung cancer cell lines.Cancer Treat Rep1987https://conductscience.org/library/papers/3038314PubMed
12291480cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.Cancer Treat Rep1979https://conductscience.org/library/papers/291480PubMed
13422420Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/422420PubMed
153607781Interaction of etoposide and cisplatin in an in vitro tumor model.Cancer Treat Rep1987https://conductscience.org/library/papers/3607781PubMed
167041539Criteria for analyzing interactions between biologically active agents.Adv Cancer Res1981https://conductscience.org/library/papers/7041539PubMed
176783143Survival analysis of drug combinations using a hazards model with time-dependent covariates.Biometrics1980https://conductscience.org/library/papers/6783143PubMed
183020696Cisplatin plus VP-16 in small-cell lung cancer.Semin Oncol1986https://conductscience.org/library/papers/3020696PubMed
192299590Isobolographic characterization of drug interactions incorporating biological variability.J Pharmacol Exp Ther1990https://conductscience.org/library/papers/2299590PubMed
207227366Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.Eur J Biochem1981https://conductscience.org/library/papers/7227366PubMed
213378962Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage.J Antimicrob Chemother1988https://conductscience.org/library/papers/3378962PubMed

See all 31 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn Papers
12644815Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.Br J Cancer2003https://conductscience.org/library/papers/12644815

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1333367

GET https://conductscience.org/api/papers/v1/1333367/references?page=2